Market Research Reports

Cardiac Prosthetic Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter Heart Valves, Implantable Pacemaker and External Pacemaker) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

80pages
Published Date: 2013-12-03
 

Description




Cardiac prosthetic devices increase the survival rate and improve the quality of life in most patients. These devices are used to replace damaged or diseased natural valves of the heart. The research report on cardiac prosthetic devices provides a detailed analysis of the global market and helps in understanding the driving forces for growth of these devices. The report also provides analysis of major segments such as heart valves (mechanical heart valves, tissue heart valves and transcatheter heart valves) and pacemakers (implantable pacemaker and external pacemaker). Market size estimates and forecasts for the period 2011 to 2019 have been given for each segment and its sub-segments, in terms of USD million, using 2012 as the base year for calculations.

The market has been segmented geographically into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Market size and forecast has been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the cardiac prosthetic devices market and future opportunities is provided in the report.

Competitive landscape for each of the product type is provided and the market players are profiled with attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of all the key players for 2012 are provided and recommendations to accentuate market shares and ensure sustainability are provided in this report. Key market players profiled are Abbott Laboratories, Boston Scientific, Medtronic, Inc., St. Jude Medical and others.

The global cardiac prosthetic devicesmarket is segmented into the following categories:
  • Cardiac Prosthetic Devices Market, by Segments
    • Heart Valves
      • Mechanical Heart Valves
      • Tissue Heart Valves
        • Stented Tissue Valve
        • Stentless Tissue Valve
      • Transcatheter Heart Valves
    • Pacemaker
      • Implantable Pacemaker
        • Single-Chamber Battery Pacemaker
        • Dual-Chamber Battery Pacemaker
        • Triple-Chamber Battery Pacemaker
      • External Pacemaker
  • Cardiac Prosthetic Devices Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents




Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research

Chapter 2 Executive Summary
2.1 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
      3.2.1 Rising Geriatric Population
      3.2.2 Rising Prevalence of Disorders such as Hypertension, Diabetes and Obesity
      3.2.3 Increasing Demand for Minimally-Invasive Procedures
3.3 Market Restraints
      3.3.1 Implementation of Affordable Healthcare Act
      3.3.2 Strict Approval Process from Government Bodies
3.4 Market Opportunities
      3.4.1 Big Opportunities in Emerging Economies with High Unmet Needs
      3.4.2 Huge Scope for Alliance with Organizations having Complementary Strength
3.5 Porter’s Five Forces Analysis for the Global Cardiac Prosthetic Devices Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of Substitutes
      3.5.4 Threat of New Entrants
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis for the Global Cardiac Prosthetic Devices Market, by Geography
3.7 Market Share by Key Players of Global Cardiac Prosthetic Devices Market, 2012
      3.7.1 Global Cardiac Prosthetic Devices Market Share, by Key Players, 2012 (%)

Chapter 4 Cardiac Prosthetic Devices Market, by Segments
4.1 Overview
      4.1.1 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
4.2 Heart Valves
      4.2.1 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
      4.2.2 Mechanical Heart Valves
               4.2.2.1 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
      4.2.3 Tissue Heart Valves
               4.2.3.1 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
               4.2.3.2 Stented Tissue Valve
                          4.2.3.2.1 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
               4.2.3.1 Stentless Tissue Valve
                          4.2.3.1.1 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
      4.2.4 Transcatheter Heart Valves
               4.2.4.1 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
4.3 Pacemaker
      4.3.1 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
      4.3.2 Implantable Pacemaker
      4.3.3 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
              4.3.3.1 Single-Chamber Battery Pacemaker
                         4.3.3.1.1 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
              4.3.3.2 Dual-Chamber Battery Pacemaker
                         4.3.3.2.1 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
              4.3.3.3 Triple-Chamber Battery Pacemaker
                         4.3.3.3.1 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
      4.3.4 External Pacemaker
              4.3.4.1 Global External Pacemaker Market, 2011 – 2019 (USD Million)

Chapter 5 Cardiac Prosthetic Devices Market, by Geography
5.1 Overview
      5.1.1 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.2 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
5.3 North America
      5.3.1 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.4 Europe
      5.4.1 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.5 Asia-Pacific
      5.5.1 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
5.6 Rest of the World (RoW)
      5.6.1 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

Chapter 6 Recommendations
6.1 Market Strategies for Success
6.2 Barriers to be Considered

Chapter 7 Company Profiles
7.1 Abbott Laboratories
      7.1.1 Company Overview
      7.1.2 Financial Overview
      7.1.3 Product Portfolio
      7.1.4 Business Strategies
      7.1.5 Recent Developments
7.2 Abiomed, Inc.
      7.2.1 Company Overview
      7.2.2 Financial Overview
      7.2.3 Product Portfolio
      7.2.4 Business Strategies
      7.2.5 Recent Developments
7.3 AtriCure, Inc.
      7.3.1 Company Overview
      7.3.2 Financial Overview
      7.3.3 Product Portfolio
      7.3.4 Business Strategies
      7.3.5 Recent Developments
7.4 Boston Scientific Corporation
      7.4.1 Company Overview
      7.4.2 Financial Overview
      7.4.3 Product Portfolio
      7.4.4 Business Strategies
      7.4.5 Recent Developments
7.5 Edward Lifesciences Corporation
      7.5.1 Company overview
      7.5.2 Financial overview
      7.5.3 Product Portfolio
      7.5.4 Business Strategies
      7.5.5 Recent Developments
7.6 Medtronic, Inc.
      7.6.1 Company Overview
      7.6.2 Financial Overview
      7.6.3 Product Portfolio
      7.6.4 Business Strategies
      7.6.5 Recent Developments
7.7 Siemens Healthcare
      7.7.1 Company Overview
      7.7.2 Financial Overview
      7.7.3 Product Portfolio
      7.7.4 Business Strategies
      7.7.5 Recent Developments
7.8 Sorin Group
      7.8.1 Company Overview
      7.8.2 Financial Overview
      7.8.3 Product Portfolio
      7.8.4 Business Strategies
      7.8.5 Recent Developments
7.9 St. Jude Medical, Inc.
      7.9.1 Company Overview
      7.9.2 Financial Overview
      7.9.3 Product Portfolio
      7.9.4 Business Strategies
      7.9.5 Recent Developments

List of Figures

FIG. 1 Cardiac Prosthetic Devices: Market Segmentation
FIG. 2 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)
FIG. 3 Porter’s Five Forces Analysis: Cardiac Prosthetic Devices Market
FIG. 4 Market Attractiveness Analysis: Global Cardiac Prosthetic Devices Market, by Geography
FIG. 5 Cardiac Prosthetic Devices: Market Share, by Key Players, 2012 (%)
FIG. 6 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)
FIG. 7 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 8 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
FIG. 9 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
FIG. 10 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 11 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 12 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 13 Global External Pacemaker Market, 2011 – 2019 (USD Million)
FIG. 14 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 15 Abbott Laboratories, Annual Revenue: 2010 – 2012 (USD Billion)
FIG. 16 Abiomed, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 17 AtriCure, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 18 Boston Scientific Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Edward Lifesciences Corporation, Net Sales: 2010 – 2012 (USD Billion)
FIG. 20 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Siemens Healthcare, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Sorin Group, Net Sales: 2010 – 2012 (USD Million)
FIG. 23 St. Jude Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Cardiac Prosthetic Devices Market (2012 & 2019)
TABLE 2 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD Million)
TABLE 3 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 4 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
TABLE 7 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 8 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 9 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
TABLE 11 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)

Enquiry Before Buying




Free Market Analysis




Cardiac prosthetics are chronic alternatives that replace a damaged or diseased part in the body.Cardiac prosthetic devices are used in the treatment of blockages in heart valves. Implantation of cardiac prosthetic devices is being increasingly accepted as one of the common procedures due to a rise in the number of patients suffering from valvular diseases. Prosthetic valve thrombosis (PVT), prosthetic valve endocarditis (PVE), mechanical hemolytic anemia and thromboembolism are some of the complications that involve the failure of primary valves.

Furthermore, these devices tend to improve the quality of life by reducing the morbidity and mortality rate by replacing diseased valves. It is been estimated that more than 60,000 patients undergo heart valve replacement in the U.S. every year. Thus, the usage and acceptance of cardiac prosthetic devices is on risemainly due to technological advances and better performance. Escalation in cardiac disorder prevalence is contributed by the factors such as rise in geriatric population, high obesity epidemic and rapidly changing lifestyle. The global cardiac prosthetic devices market was valued at USD 2,945.3 million in the year 2012 and is expected to record a growth rate of 8.7% during the forecast period from 2013 to 2019, to reach an estimated value of USD 5,290.0 million by 2019.

The cardiac prosthetic devices market can be analyzed by the types of heart valves and pacemakers. The various types of heart valves currently available are mechanical heart valves, tissue heart valves and transcatheter heart valves. These devices are used to replace the affectedheart valves in patients. Heart valve disorders can arise from three types of malfunction: regurgitation, stenosis and atresia. A heart valve disease, if not treated in time, can lead to various heart diseases such as stroke, heart failure, cardiac arrest and blood clots. Rising geriatric population, changing lifestyle and increasing partnership among vendors are the factors influencing the growth of the heart valves market globally. Pacemakers are further categorized as implantable pacemaker and external pacemaker. Pacemakers are cardiac prosthetic devices that assist in controlling abnormal heart rhythms. These devices are implanted in patients suffering from cardiac arrhythmia, a heart disorder featured by an uneven pattern of heartbeats.

Geographically, North America accounts for the largest percentage share of the global cardiac prosthetic devices market accounting for over35% of the total market. This is justified by the presence of technologically updated infrastructure and well trained healthcare professionalsin this region compared to other regions. In addition, rising prevalence of cardiac diseases and established healthcare policies has further augmented the growth and development of cardiac prosthetic devices market in this region.Asia-Pacific region is anticipated to record high growth rate owing to increased participation of respective governments in improving the overall healthcare sector and huge untapped potential in these regions. In addition, rise in disposable incomes and increased preference of the population to avail technologically advanced medical solutions further support the growth of cardiac prosthetic devices market. 

The overall cardiac prosthetic devices market is highly fragmented with the presence of both established and emerging companies in this field that includes Edwards Lifesciences Corporation, Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Sorin Group and others. The factors that contribute in the growth of overall cardiac prosthetic devices are continuous product modifications and upgradations followed by technological advances and increased preference for minimally invasive procedures. However, high cost of the products and procedures may limit the growth prospects for the development of cardiac prosthetic devices market.

global-cardiac-prosthetic-devices-market-by-segments-2012
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research